Michael M. Tarnow
Chairman chez Ferghana Partners Group
Profil
Michael M.
Tarnow is currently the Non-Executive Chairman at Ferghana Partners Group since 2011.
He is also the Director at Massachusetts College of Art & Design, The Food & Drug Law Institute, and Massachusetts College of Art Foundation.
Previously, Mr. Tarnow served as the President, Chief Executive Officer & Director at Creative Biomolecules, Inc. from 1995 to 2000.
He was also the President & Chief Executive Officer at Merck Frosst Canada Ltd.
Additionally, he held the position of Executive Chairman at CASI Pharmaceuticals, Inc. from 2003 to 2012.
He served as the Chairman at Xenon Pharmaceuticals, Inc. from 1999 to 2021.
Mr. Tarnow has also held positions as a Director at Aptalis Pharma Canada ULC, Caprion Pharmaceuticals, Inc., Thallion Pharmaceuticals, Inc., and CellCarta Biosciences, Inc. He was the President at Merck & Co., Inc. from 1973 to 1995.
He served as a Member-Supervisory Board at MediGene AG from 2001 to 2007.
Additionally, he was the Senior Executive Vice President at Merck-Medco Managed Care LLC.
He also worked as an Advisor at Puretech Health LLC.
Mr. Tarnow completed his undergraduate studies at Wayne State University (Michigan) and obtained a graduate degree from the University of Illinois College of Law.
Postes actifs de Michael M. Tarnow
| Sociétés | Poste | Début |
|---|---|---|
| Massachusetts College of Art & Design | Director/Board Member | - |
Ferghana Partners Group
 Ferghana Partners Group Investment ManagersFinance Ferghana Partners Group provides healthcare corporate finance advisory services. | Chairman | 01/01/2003 |
| Massachusetts College of Art Foundation | Director/Board Member | - |
The Food & Drug Law Institute
 The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022. | Director/Board Member | 19/11/2009 |
Anciens postes connus de Michael M. Tarnow
| Sociétés | Poste | Fin |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chairman | 03/06/2021 |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Chairman | 06/02/2012 |
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Caprion Pharmaceuticals, Inc. discovered and developed pharmaceutical products. It offered a proprietary therapeutic pipeline in oncology and infectious diseases. Caprion Pharmaceuticals proteomics discovery technologies used to enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly enhance clinical development productivity and decision making. The company was founded in 1998 and was headquartered in Montreal, Canada. | Director/Board Member | 16/03/2007 |
| MEDIGENE AG | Director/Board Member | 31/01/2007 |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Chief Executive Officer | 01/01/2000 |
Formation de Michael M. Tarnow
| Wayne State University (Michigan) | Undergraduate Degree |
| University of Illinois College of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MEDIGENE AG | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada. | Health Technology |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Caprion Pharmaceuticals, Inc. discovered and developed pharmaceutical products. It offered a proprietary therapeutic pipeline in oncology and infectious diseases. Caprion Pharmaceuticals proteomics discovery technologies used to enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly enhance clinical development productivity and decision making. The company was founded in 1998 and was headquartered in Montreal, Canada. | Health Technology |
Ferghana Partners Group
Ferghana Partners Group Investment ManagersFinance Ferghana Partners Group provides healthcare corporate finance advisory services. | Finance |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck-Medco Managed Care LLC discovers, develops, and markets a broad range of human and animal health products. The private company is based in Whitehouse Station, NJ. | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada. | Health Technology |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Health Technology |
The Food & Drug Law Institute
The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022. | Commercial Services |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
| Massachusetts College of Art Foundation |
